MEG to track brain changes after focused ultrasound for essential tremor
Official title: Network Characteristics in Essential Tremor (ET) Patients Undergoing High-Intensity Focused Ultrasound (HiFU): a Magnetoencephalography (MEG) Pilot Study
Run by University of Florida · NCT07446192 · Data updated 2026-11-12
This project uses MEG and MRI to see how high‑intensity focused ultrasound (HiFU) changes brain activity in people aged 50–84 with essential tremor who haven't responded to at least two medications.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 50 Years to 84 Years |
| Sex | All |
| Enrollment | 10 (estimated) |
| Sponsor | University of Florida Academic / other |
| Locations | 1 site (Gainesville, Florida) |
| Status | Recruiting |
| Started | February 17, 2026 |
| Main results expected | August 2027 |
| Study ends | August 2027 |
| Registry record updated | September 30, 2026 |
| Trial ID | NCT07446192 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are people aged 50–84 with essential tremor not controlled by at least two first-line tremor medications and with a skull density ratio (SDR) ≥ 0.35 who can undergo MRI/MEG and travel to UF Health in Gainesville.
✕Probably not a fit
People with MR/MEG‑incompatible implants, severe depression or anxiety, severe cognitive impairment, or head tremor that prevents usable MEG recordings are unlikely to benefit from participation or will be excluded.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional pilot follows participants for about eight months with six in-person visits, including a screening, a pre-treatment assessment, and post-treatment follow-ups at 1 day, 6 weeks, and 6 months. Participants receive HiFU treatment for tremor and undergo non-invasive brain imaging with magnetoencephalography (MEG) and functional MRI (fMRI), along with sensor-based motor assessments and self-report questionnaires. The study compares brain network activity and motor function before and after treatment to identify how HiFU alters neural circuits linked to tremor. Data are collected at a single site (UF Health, Gainesville) using standardized imaging and motor testing protocols.
Why it matters
Potential benefit: If successful, this work could clarify how HiFU reduces tremor and help clinicians better target treatment or select patients likely to benefit.
How similar studies have gone: Previous MR‑guided focused ultrasound (HiFU/MRgFUS) studies have shown meaningful tremor reduction and some imaging work has detected network changes, but using MEG longitudinally in this context is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion: * Age \>50 years and \<85 years * Refractory to at least 2 first line tremor medications * Skull Density Ratio (SDR) \> = 0.35 Exclusion: * MR/MEG incompatible implants and implantable devices (ex: pacemaker) * Head tremor interfering with MEG recording * Severe depression and/or anxiety * Severe cognitive impairment
Where it's running
-
UF Health
Gainesville, Florida, United States Recruiting
Study contacts
- Principal investigator: Justin Hilliard, MD — University of Florida
- Study coordinator: Kerstin Rodriguez, CCMA, CPT
- Email: Kerstin.Rodriguez@neurosurgery.ufl.edu
- Phone: 352-273-9000
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Encora X1 in Daily Life for Essential Tremor
This real-world study tests how the Encora X1 wrist device affects day-to-day activities for adults with essential tremor over three years.
-
Intraoperative Microelectrode Recordings with MAVEN vs Standard Equipment
This study tests whether MAVEN can match the recording data collected during DBS surgery for movement disorders using standard equipment.
-
Microelectrode-based brain stimulation for Parkinson’s and essential tremor
This early feasibility test checks a new microelectrode-based brain stimulation method in adults with Parkinson’s disease or essential tremor who are already getting deep brain stimulation implants.
-
Non-Invasive Nerve Stimulation for Essential Tremor: Long-Term Safety and Effectiveness
This study tests whether a non-invasive stimulation device called TAPS helps reduce tremor in adults with essential tremor over a long period.
-
Low Intensity Focused Ultrasound for Essential Tremor in Adults
This early-stage, open-label study tests whether repeated low-intensity focused ultrasound can safely and briefly modulate tremor in people with essential tremor.
-
Closed-loop TMS to reduce tremor
This trial tries phase-locked transcranial magnetic stimulation (TMS) to reduce tremor in people with essential tremor or Parkinson's disease.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.